These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38228909)

  • 1. CCDC92 promotes podocyte injury by regulating PA28α/ABCA1/cholesterol efflux axis in type 2 diabetic mice.
    Zuo FW; Liu ZY; Wang MW; Du JY; Ding PZ; Zhang HR; Tang W; Sun Y; Wang XJ; Zhang Y; Xie YS; Wu JC; Liu M; Wang ZY; Yi F
    Acta Pharmacol Sin; 2024 May; 45(5):1019-1031. PubMed ID: 38228909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
    Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice.
    Yin QH; Zhang R; Li L; Wang YT; Liu JP; Zhang J; Bai L; Cheng JQ; Fu P; Liu F
    J Biol Chem; 2016 Dec; 291(51):26487-26501. PubMed ID: 27784780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small GTPase Arf6 regulates diabetes-induced cholesterol accumulation in podocytes.
    Hu J; Yang Q; Chen Z; Liang W; Feng J; Ding G
    J Cell Physiol; 2019 Dec; 234(12):23559-23570. PubMed ID: 31206670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling.
    Kang JS; Cho NJ; Lee SW; Lee JG; Lee JH; Yi J; Choi MS; Park S; Gil HW; Oh JC; Son SS; Park MJ; Moon JS; Lee D; Kim SY; Yang SH; Kim SS; Lee ES; Chung CH; Park J; Lee EY
    Metabolism; 2024 Oct; 159():155982. PubMed ID: 39089491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Wu M; Yoon CY; Park J; Kim G; Nam BY; Kim S; Park JT; Han SH; Kang SW; Yoo TH
    Diabetologia; 2024 Sep; 67(9):1980-1997. PubMed ID: 38879617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.
    Ducasa GM; Mitrofanova A; Mallela SK; Liu X; Molina J; Sloan A; Pedigo CE; Ge M; Santos JV; Hernandez Y; Kim JJ; Maugeais C; Mendez AJ; Nair V; Kretzler M; Burke GW; Nelson RG; Ishimoto Y; Inagi R; Banerjee S; Liu S; Szeto HH; Merscher S; Fontanesi F; Fornoni A
    J Clin Invest; 2019 Jul; 129(8):3387-3400. PubMed ID: 31329164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism.
    Fu Y; Sun Y; Wang M; Hou Y; Huang W; Zhou D; Wang Z; Yang S; Tang W; Zhen J; Li Y; Wang X; Liu M; Zhang Y; Wang B; Liu G; Yu X; Sun J; Zhang C; Yi F
    Cell Metab; 2020 Dec; 32(6):1052-1062.e8. PubMed ID: 33186558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin protects podocytes in diabetic kidney disease.
    Merscher-Gomez S; Guzman J; Pedigo CE; Lehto M; Aguillon-Prada R; Mendez A; Lassenius MI; Forsblom C; Yoo T; Villarreal R; Maiguel D; Johnson K; Goldberg R; Nair V; Randolph A; Kretzler M; Nelson RG; Burke GW; Groop PH; Fornoni A;
    Diabetes; 2013 Nov; 62(11):3817-27. PubMed ID: 23835338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury.
    Zhao Y; Fan S; Zhu H; Zhao Q; Fang Z; Xu D; Lin W; Lin L; Hu X; Wu G; Min J; Liang G
    Nat Commun; 2024 Jun; 15(1):5441. PubMed ID: 38937512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.
    Zhang Y; Xia S; Tian X; Yuan L; Gao Y; Liu D; Qi H; Wang S; Liu Z; Li Y; Zhao Z; Liu W
    FASEB J; 2024 May; 38(10):e23668. PubMed ID: 38742811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of STARD3-mediated cholesterol transport alleviates diabetes-induced podocyte injury by reducing mitochondrial cholesterol accumulation.
    Hu J; Zhu Z; Zhang Z; Hu H; Yang Q
    Life Sci; 2024 Jul; 349():122722. PubMed ID: 38754814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease.
    Zhang J; Wu Y; Zhang J; Zhang R; Wang Y; Liu F
    Metabolism; 2023 Feb; 139():155377. PubMed ID: 36521550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP2 induces podocyte apoptosis promoted by mitochondrial damage via integrin α5/FAK in diabetic kidney disease.
    Wang X; Zhang Y; Chi K; Ji Y; Zhang K; Li P; Fu Z; Wang X; Cui S; Shen W; Cai G; Chen X; Zhu H; Hong Q
    Apoptosis; 2024 Aug; 29(7-8):1109-1125. PubMed ID: 38796567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
    Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
    J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.
    Pedigo CE; Ducasa GM; Leclercq F; Sloan A; Mitrofanova A; Hashmi T; Molina-David J; Ge M; Lassenius MI; Forsblom C; Lehto M; Groop PH; Kretzler M; Eddy S; Martini S; Reich H; Wahl P; Ghiggeri G; Faul C; Burke GW; Kretz O; Huber TB; Mendez AJ; Merscher S; Fornoni A
    J Clin Invest; 2016 Sep; 126(9):3336-50. PubMed ID: 27482889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.